Shares of Integer Holdings Corporation (NYSE:ITGR – Get Free Report) have earned a consensus recommendation of “Hold” from the ten research firms that are currently covering the company, MarketBeat Ratings reports. Six equities research analysts have rated the stock with a hold rating and four have issued a buy rating on the company. The average 12 month price objective among analysts that have updated their coverage on the stock in the last year is $102.00.
Several analysts have weighed in on the company. Wall Street Zen downgraded Integer from a “buy” rating to a “hold” rating in a research note on Sunday, January 25th. Wells Fargo & Company lifted their target price on Integer from $72.00 to $84.00 and gave the stock an “equal weight” rating in a report on Friday, February 20th. Raymond James Financial reiterated an “outperform” rating and issued a $101.00 target price on shares of Integer in a research report on Monday, February 23rd. Weiss Ratings upgraded shares of Integer from a “sell (d+)” rating to a “hold (c-)” rating in a report on Tuesday, February 24th. Finally, Truist Financial raised their price target on shares of Integer from $95.00 to $97.00 and gave the stock a “buy” rating in a research report on Friday, February 20th.
Read Our Latest Report on Integer
Insider Buying and Selling at Integer
Institutional Investors Weigh In On Integer
Several hedge funds have recently added to or reduced their stakes in ITGR. Tudor Investment Corp ET AL raised its stake in shares of Integer by 50,787.5% during the 3rd quarter. Tudor Investment Corp ET AL now owns 29,500,000 shares of the medical equipment provider’s stock valued at $28,606,000 after buying an additional 29,442,029 shares during the last quarter. Irenic Capital Management LP purchased a new stake in shares of Integer in the fourth quarter worth about $99,109,000. Alliancebernstein L.P. grew its holdings in Integer by 885.1% during the second quarter. Alliancebernstein L.P. now owns 1,106,091 shares of the medical equipment provider’s stock worth $136,016,000 after acquiring an additional 993,810 shares during the period. Millennium Management LLC raised its position in Integer by 3,350.2% during the fourth quarter. Millennium Management LLC now owns 677,108 shares of the medical equipment provider’s stock valued at $53,106,000 after acquiring an additional 657,483 shares in the last quarter. Finally, J. Goldman & Co LP purchased a new position in Integer during the fourth quarter valued at approximately $40,531,000. 99.29% of the stock is owned by hedge funds and other institutional investors.
Integer Trading Up 1.1%
Shares of Integer stock opened at $86.23 on Friday. The firm’s 50 day simple moving average is $85.66 and its two-hundred day simple moving average is $84.61. The firm has a market capitalization of $2.97 billion, a price-to-earnings ratio of 30.05, a PEG ratio of 1.44 and a beta of 0.75. Integer has a 12-month low of $62.00 and a 12-month high of $127.56. The company has a current ratio of 3.32, a quick ratio of 2.23 and a debt-to-equity ratio of 0.69.
Integer (NYSE:ITGR – Get Free Report) last posted its quarterly earnings data on Thursday, February 19th. The medical equipment provider reported $1.76 EPS for the quarter, topping the consensus estimate of $1.70 by $0.06. Integer had a net margin of 5.55% and a return on equity of 13.26%. The business had revenue of $472.06 million during the quarter, compared to the consensus estimate of $462.73 million. During the same period in the previous year, the firm posted $1.43 earnings per share. The business’s revenue for the quarter was up 5.0% compared to the same quarter last year. Integer has set its FY 2026 guidance at 6.290-6.780 EPS. Analysts predict that Integer will post 6.01 EPS for the current year.
About Integer
Integer Holdings Corporation (NYSE: ITGR) is a global provider of outsourced medical device design, development and manufacturing solutions. The company partners with leading medical technology firms to deliver complex components, subsystems and finished devices across a range of therapeutic areas. Its services encompass concept and product design, precision machining, microelectronic assembly, terminal sterilization and regulatory support, enabling customers to accelerate time to market and optimize product performance.
Integer’s product portfolio is organized into two core segments: Advanced Delivery and MedTech.
Read More
Receive News & Ratings for Integer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integer and related companies with MarketBeat.com's FREE daily email newsletter.
